Oxyntomodulin

Oxyntomodulin (OXM) is a 37-amino acid peptide hormone produced in the intestine that activates both GLP-1 and glucagon receptors. It is studied for its potential roles in appetite suppression and blood sugar regulation.

In the literature, Oxyntomodulin appears most often in work focused on appetite control, blood sugar and weight loss. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.

Because it is catalogued here under powder peptides, Oxyntomodulin also shows up in discussions of metabolism. Coverage across those topics varies widely in quality and depth, and much of it is early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.